Advertisement

Pharmaceutisch weekblad

, Volume 1, Issue 1, pp 970–982 | Cite as

Referaten

Article
  • 18 Downloads

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatuur

  1. Bartlett, J. G., e.a. (1978)New Engl. J. Med. 298, 531.CrossRefPubMedGoogle Scholar
  2. George, W. L., e.a. (1978)Lancet I, 802.CrossRefGoogle Scholar
  3. Kappas, A., e.a. (1978)Brit. Med. J. I, 675.CrossRefGoogle Scholar
  4. Keighley, M. R. B., e.a. (1978)Brit. Med. J. 2, 1667.CrossRefPubMedPubMedCentralGoogle Scholar
  5. Larson, H. E., e.a. (1977a)Brit. Med. J. 1, 1246; (1977b)Lancet II, 1312; (1978)Lancet I, 1063.CrossRefPubMedPubMedCentralGoogle Scholar
  6. Rifkin, G. D., e.a. (1977)Lancet II, 1103.CrossRefGoogle Scholar
  7. Tedesco, F., e.a. (1978)Lancet I, 226.CrossRefGoogle Scholar

Literatuur

  1. Drug. Therap. Bull. (1979) Sodium Cromoglycate for use in the gut (Nalcrom),17, 10–12.Google Scholar
  2. Dissanayake, A. S., e.a. (1973) Controlled therapeutical trial of long Term maintenance treatment of ulcerative colitis with sulphasalazine,Gut 14, 923–926.CrossRefPubMedPubMedCentralGoogle Scholar
  3. Editorial (1976) New treatment for ulcerative colitis?Brit. Med. J. 1, 2. Google Scholar
  4. Heatley, R., e.a. (1975) Disodium cromoglycate in the treatment of chronic proctitis.Gut 16, 559–563; (1975) Immunoglobulin E in rectal mucosa of patients with proctitis,Lancet II, 1010–1012.CrossRefPubMedPubMedCentralGoogle Scholar
  5. Hees, P. A. M. Van, e.a. (1978) Active therapeutic moiety of sulphasalazine,Lancet I, 277.CrossRefGoogle Scholar
  6. Mani, V., e.a. (1976) Treatment of ulcerative colitis with oral disodium cromoglycate,Lancet I, 439–441.CrossRefGoogle Scholar
  7. Reyken, M. J. M., Van De (1978) referaatPharm. Weekblad 113, 323–324.Google Scholar
  8. Willoughby, C. P., e.a. (1979) Comparison of disodium cromoglycate and sulphasalazine as maintenance therapy for ulcerative colitis,Lancet I, 119–121.CrossRefGoogle Scholar

Literatuur

  1. Brouwers, J. R. B. J., enG. N. Tytgat (1978) Biopharmaceutical properties of liquid and tablet antacids: in. vivo studies using the intragastric pH-measurement technique,J. Pharm. Pharmacol. 30, 148–151.CrossRefPubMedGoogle Scholar
  2. Caspary, W. F., enS. Graf (1978) Bindung von Gallensäuren an Antacida,Deut. Med. Wschr. 103, 825–827.CrossRefPubMedGoogle Scholar
  3. Caspary, W. F., enH. Kausch (1978) Effects of bile acids, antacids and cholestyramine on transmural electrical potential difference in man,Acta Hepato-Gastroenterol. 25, 369–375.Google Scholar

Literatuur

  1. Cohen, S. (1978)J. Am. Med. Assoc. 240, 1761–1768.CrossRefGoogle Scholar
  2. Green, K., K. Kim enK. Bowman (1976) In:The therapeutic potential marihuana (Ed.Cohen enStellman), Plenum Publ. Corp., New York, blz. 49–61.CrossRefGoogle Scholar
  3. Hepler, R. S., enI. M. Frank (1971)J. Am. Med. Assoc. 217, 1392.CrossRefGoogle Scholar
  4. Innemee, H. C. (1979)De farmacologische beÏnvloeding van de intra-oculaire druk via het centrale zenuwstelsel. Proefschrift, Amsterdam, blz. 102–114.Google Scholar
  5. Kabalik, J., Z. Krejci enF. Santany (1960)Bull. Narcotics 12, 5–19.Google Scholar
  6. Karler, R., enS. A. Turkanis (1976) In:The therapeutic potentials of Marihuana (Ed.Cohen enStillman). Plenum Publ. Corp., New York, blz. 383–397.CrossRefGoogle Scholar
  7. Montgomery, B. J. (1978)J. Am. Med. Assoc. 240, 1469–1470.CrossRefGoogle Scholar
  8. Regelson, W., J. R. Butler enJ. Schutz (1976) In:Pharmacology of Marihuana (Ed.)Braude enSzara). Raven Press, New York, blz. 763–776.Google Scholar
  9. Tashkin, D. P., B. J. Shapiro enI. M. Frank (1973)New Engl. J. Med. 289, 336–341.CrossRefPubMedGoogle Scholar
  10. Vachon, L., e.a. (1973)New Engl. J. Med. 288, 985–989.CrossRefPubMedGoogle Scholar

Literatuur

  1. Gazzard, B. G., e.a. (1974)Brit. J. Exp. Pathol. 55, 601.Google Scholar
  2. Gilbertson, A. A., e.a. (1978)Lancet 1, 856–857.Google Scholar
  3. Glerum, J. H. (1978)Pharm. Weekblad 113, 601–602.Google Scholar
  4. Heijst, A. N. P. Van, enS. A. Pikaar (1978)Vademecum Vergiftigingen 1978, Elsevier, Amsterdam/Brussel blz. 126–128.Google Scholar
  5. Loenen, A. C. Van, A. Van Duk enA. N. P. Van Heijst, ongepubliceerde resultaten.Google Scholar
  6. Mitchell, J. R., e.a. (1974)Clin. Pharmacol. Therap. 16, 676–684.CrossRefGoogle Scholar
  7. Peterson, R. G., enB. H. Rumack (1978)Jacep 7, 202–205.CrossRefPubMedGoogle Scholar
  8. Prescott, L. F., e.a. (1976)Lancet 2, 109–113.CrossRefPubMedGoogle Scholar
  9. Strubelt, O., e.a. (1974)Arch. Toxikol. 33, 55.Google Scholar
  10. Weiner, K. (1978)Ann. Clin. Biochem. 15, 187–196.CrossRefGoogle Scholar
  11. Zwieten, P. A. Van, (1979)Ned. Tijdschr. Geneesk. 123, 294–296.Google Scholar

Copyright information

© Bohn, Scheltema & Holkema 1979

Personalised recommendations